Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
în cazul în care terapia estrogenică în doze reduse a
Yüklə 4,39 Mb.
|
- Bu səhifədəki naviqasiya:
- Estradiol trebuie folosit împreună cu un progestativ oral la femeile nehisterectomizate.
- SUBLISTA C2 - P9: PROGRAM NAŢIONAL DE TRANSPLANT DE ORGANE, ŢESUTURI ŞI CELULE DE ORIGINE UMANĂ. P9.1: TRANSPLANT MEDULAR
| în cazul în care terapia estrogenică în doze reduse a
demonstrat intoleranţă la administrarea orală cu estrogeni. Această limitare este valabilă doar pentru formele farmaceutice Sistem terapeutic transdermic şi plasture transdermic. NOTĂ: Estradiol trebuie folosit împreună cu un progestativ oral la femeile nehisterectomizate. Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ G03CA03 ESTRADIOLUM GEL 0.06% OESTROGEL(R) 0.06% LAB. BESINS INTERNATIONAL
ESTREVA(R) 0.1% LAB. THERAMEX G03CA03 ESTRADIOLUM COMPR. FILM. 1 mg ESTROFEM 1 mg 1 mg NOVO NORDISK A/S G03CA03 ESTRADIOLUM COMPR. VAG. 25 µg VAGIFEM 25 µg NOVO NORDISK A/S G03CA03 ESTRADIOLUM IMPLANT 25 mg RISELLE 25 mg 25 mg ORGANON NV G03CA03 ESTRADIOLUM PLASTURE TRANSDERM. 50 µg/24 ore CLIMARA 50 µg/24 ore SCHERING AG ________________________________________________________________________________
| 854 |G03DC05| TIBOLONUM | Protocol: G007N | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ G03DC05 TIBOLONUM COMPR. 2,5 mg LADYBON 2,5 mg ZENTIVA A.S.
LIVIAL(R) 2.5 mg 2.5 mg ORGANON NV ________________________________________________________________________________
| 855 |G03FA15| ESTRADIOLUMVALERAT + DIENOGEST | Protocol: G002N | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ G03FA15 ESTRADIOLUMVALERAT + DRAJ. DIENOGEST KLIMODIEN SCHERING AG ________________________________________________________________________________
| 856 |G03XC01| RALOXIFENUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ G03XC01 RALOXIFENUM COMPR. FILM. 60 mg EVISTA 60 mg 60 mg ELI LILLY NEDERLAND BV ________________________________________________________________________________ ______________________________________________________________________________ | 857 |H01AB01| TIREOTROPINUM ALFA | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H01AB01 TIREOTROPINUM ALFA PULB. PT. SOL. INJ. 0.9 mg THYROGEN 0.9 mg 0.9 mg GENZYME EUROPE BV ________________________________________________________________________________ ______________________________________________________________________________ | 858 |H02AB04| METHYLPREDNISOLONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 125 mg LEMOD SOLU 125 mg 125 mg HEMOFARM S.R.L.
INJ.
SOLU-MEDROL ACT-O-VIAL 125 mg/2 ml PFIZER EUROPE MA EEIG H02AB04 METHYLPREDNISOLONUM COMPR. 16 mg MEDROL A 16 16 mg PFIZER EUROPE MA EEIG H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 20 mg LEMOD SOLU 20 mg 20 mg HEMOFARM S.R.L. H02AB04 METHYLPREDNISOLONUM LIOF. ŞI SOLV. PT. SOL. 250 mg/4 ml INJ.
SOLU-MEDROL ACT-O-VIAL 250 mg/4 ml PFIZER EUROPE MA EEIG H02AB04 METHYLPREDNISOLONUM COMPR. 32 mg MEDROL 32 32 mg PFIZER EUROPE MA EEIG H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 40 mg LEMOD SOLU 40 mg 40 mg HEMOFARM S.R.L. H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV. PT. SOL. 40 mg/1 ml INJ.
SOLU-MEDROL ACT-O-VIAL 40 mg/1 ml PFIZER EUROPE MA EEIG H02AB04 METHYLPREDNISOLONUM COMPR. 4 mg MEDROL 4 mg 4 mg PFIZER EUROPE MA EEIG H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 500 mg LEMOD SOLU 500 mg 500 mg HEMOFARM S.R.L. H02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. 500 mg/7.8 ml INJ.
SOLU-MEDROL 500 mg/7,8 ml 500 mg/7.8 ml PFIZER EUROPE MA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 859 |H03AA01| LEVOTHYROXINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H03AA01 LEVOTHYROXINUM COMPR. 100 µg EUTHYROX(R) 100 100 µg MERCK KGAA L-THYROXIN 100 100 µg BERLIN CHEME AG BERLIN-CHEME MENARINI GROUP
EUTHYROX(R) 200 200 µg MERCK KGAA H03AA01 LEVOTHYROXINUM COMPR. 25 µg EUTHYROX(R) 25 25 µg MERCK KGAA H03AA01 LEVOTHYROXINUM COMPR. 50 µg EUTHYROX(R) 50 50 µg MERCK KGAA L-THYROXIN 50 50 µg BERLIN CHEME AG MENARINI GROUP
________________________________________________________________________________ ______________________________________________________________________________ | 860 |H03AAN1| LEVOTHYROXINUM + KALII IODIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H03AAN1 LEVOTHYROXINUM + COMPR. KALII IODIDUM JODTHYROX(R) 100/130,8 MERCK KGAA ________________________________________________________________________________
| 861 |H03BB02| THIAMAZOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H03BB02 THIAMAZOLUM COMPR. FILM. 10 mg THYROZOL(R) 10 mg 10 mg MERCK KGAA
THYROZOL(R) 20 mg 20 mg MERCK KGAA H03BB02 THIAMAZOLUM COMPR. FILM. 5 mg THYROZOL(R) 5 mg 5 mg MERCK KGAA ________________________________________________________________________________
| 862 |H03CA01| KALII IODIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H03CA01 KALII IODIDUM COMPR. 100 µg JODID 100 100 µg MERCK KGAA
JODID 200 200 µg MERCK KGAA ________________________________________________________________________________
| 863 |H05AA02| TERIPARATIDUM** | Protocol: M003M | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H05AA02 TERIPARATIDUM SOL. INJ. 20 µg/80 µg FORSTEO 20 µg/80 µg 20 µg/80 µg ELI LILLY NEDERLAND BV ________________________________________________________________________________ ______________________________________________________________________________ | 864 |H05BA01| CALCITONINUM (SOMON) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H05BA01 CALCITONINUM (SOMON) SOL. INJ. 100 UI TONOCALCIN 100 UI 100 UI ALFA WASSERMANN SPA
NYLEX 100 UI/doza 100 UI/doza PHARMACEUTICAL IND. PROEL EPAM. G. CORONIS SA
NYLEX(R) 10O UI/ml PROEL E.P. CORONIS SA H05BA01 CALCITONINUM (SOMON) SPRAY NAZAL - SOL. 200 UI/doza MIACALCIC(R) NASAL 200 200 ui/doza NOVARTIS PHARMA GMBH NYLEX(R) 200 UI/doza PROEL E.P. CORONIS SA
MIACALCIC(R) 50 ui/ml NOVARTIS PHARMA GMBH ________________________________________________________________________________
| 865 |M05BA04| ACIDUM ALENDRONICUM** | Protocol: M003M | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ M05BA04 ACIDUM ALENDRONICUM COMPR. 10 mg FOSAMAX 10 mg 10 mg MERCK SHARP & DOHME S.R.L.
TEVA NAT 70 mg TEVA PHARMACEUTICALS SRL M05BA04 ACIDUM ALENDRONICUM COMPR. 70 mg FOSAMAX 70 mg 70 mg MERCK SHARP & DOHME S.R.L. ________________________________________________________________________________
| 866 |M05BA06| ACIDUM IBANDRONICUM** | Protocol: M003M | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ M05BA06 ACIDUM IBANDRONICUM SOL. INJ. IN SERINGA 3 mg/3 ml PREUMPLUTA BONVIVA 3 mg/3 ml 3 mg/3 ml ROCHE REGISTRATION LTD M05BA06 ACIDUM IBANDRONICUM CONC. PT. SOL. PERF. BONDRONAT 6 mg/6 ml 6 mg/6 ml ROCHE REGISTRATION L M05BA06 ACIDUM IBANDRONICUM COMPR. FILM. BONDRONAT 50 mg 50 mg ROCHE REGISTRATION L M05BA06 ACIDUM IBANDRONICUM COMPR. FILM. BONDRONAT 50 mg 50 mg ROCHE REGISTRATION L ________________________________________________________________________________
| 867 |M05BA07| ACIDUM RISEDRONICUM** | Protocol: M003M | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ M05BA07 ACIDUM RISEDRONICUM COMPR. FILM. 35 mg ACTONEL(R) SAPTAMANAL 35 mg AVENTIS PHARMA AB RISENDROS 35 mg 35 mg ZENTIVA A.S. ________________________________________________________________________________
| 868 |M05BB03| COMBINATII (ACIDUM ALENDRONICUM + | Protocol: M003M | | | | COLECALCIFEROLUM)** | | |_______|_______|____________________________________________|_________________| ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ M05BB03 COMBINATII (ACIDUM COMPR. 70 mg/2800 UI ALENDRONICUM + COLECALCIFEROLUM) FOSAVANCE 70 mg/2800 UI 70 mg/2800 UI MERCK SHARP & DOHME LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 869 |M05BX03| STRONTIUM RANELATUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ M05BX03 STRONTIUM RANELATUM GRAN. PT. SUSP. ORALA 2 g OSSEOR 2 g 2 g LES LAB. SERVIER ________________________________________________________________________________ ______________________________________________________________________________ | 872 |M05BA08| ACIDUM ZOLEDRONICUM** | Protocol: M001M | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ M05BA08 ACIDUM ZOLEDRONICUM SOL. PERF. 5 mg/100 ml ACLASTA 5 mg/100 ml 5 mg/100 ml NOVARTIS EUROPHARM LTD.
PERF.
ZOMETA 4 mg 4 mg NOVARTIS EUROPHARM L ________________________________________________________________________________ ______________________________________________________________________________ | 1218 |H03BB01| CARBIMAZOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H03BB01 CARBIMAZOLUM COMPR. FILM. 5 mg CARBIMAZOLE 5 5 mg REMEDICA LTD. ________________________________________________________________________________ SUBLISTA C2 - P9: PROGRAM NAŢIONAL DE TRANSPLANT DE ORGANE, ŢESUTURI ŞI CELULE DE ORIGINE UMANĂ. P9.1: TRANSPLANT MEDULAR ______________________________________________________________________________ | 873 |A04AA01| ONDANSETRONUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ A04AA01 ONDANSETRONUM SOL. INJ. OSETRON 4 mg 2 mg/ml DR. REDDY'S LABORATO OSETRON 8 mg 2 mg/ml DR. REDDY'S LABORATORIES A04AA01 ONDANSETRONUM SOL. INJ./PERF. 2 mg/ml EMESET 4 mg/2 ml 2 mg/ml CIPLA (UK) LIMITED EMESET 8 mg/4 ml 2 mg/ml CIPLA (UK) LIMITED
ONDANSETRON TEVA 4 mg 4 mg TEVA PHARMACEUTICALS SRL ONDANTOR 4 mg 4 mg SANDOZ SRL OSETRON 4 mg 4 mg DR. REDDY'S LABORATORIES SETRONON 4 mg 4 mg PLIVA LJUBLJANA D.O.O. ZOFRAN 4 mg 4 mg GLAXO WELLCOME UK LTD. A04AA01 ONDANSETRONUM COMPR. ORODISPERSABILE 4 mg ONDARAN MD 4 mg 4 mg RANBAXY UK LTD. A04AA01 ONDANSETRONUM SOL. INJ. 4 mg/2 ml ZOFRAN 4 mg/2 ml 4 mg/2 ml GLAXO WELLCOME UK LIMITED A04AA01 ONDANSETRONUM SOL. INJ./PERF. 4 mg/2 ml SETRONON 4 mg/2 ml 4 mg/2 ml PLIVA LJUBLJANA D.O.O. A04AA01 ONDANSETRONUM COMPR. FILM. 8 mg ONDANSETRON TEVA 8 mg 8 mg TEVA PHARMACEUTICALS SRL ONDANTOR 8 mg 8 mg SANDOZ SRL OSETRON 8 mg 8 mg DR. REDDY'S LABORATORIES (UK) LTD SETRONON 8 mg 8 mg PLIVA LJUBLJANA D.O.O. ZOFRAN 8 mg 8 mg GLAXO WELLCOME UK LTD.
ONDARAN MD 8 mg 8 mg RANBAXY UK LIMITED A04AA01 ONDANSETRONUM SOL. INJ. 8 mg/4 ml ZOFRAN 8 mg/4 ml 8 mg/4 ml GLAXO WELLCOME UK LIMITED A04AA01 ONDANSETRONUM SOL. INJ./PERF. 8 mg/4 ml SETRONON 8 mg/4 ml 8 mg/4 ml PLIVA LJUBLJANA D.O.O. ________________________________________________________________________________
| 874 |A05AA02| ACIDUM URSODEOXYCHOLICUM | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|